Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell Leukemia.

Saved in:
Bibliographic Details
Title: Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell Leukemia.
Authors: Laurent AP; INSERM U1170, Gustave Roussy Institute, Université Paris Saclay, Villejuif, France.; Université Paris Diderot, Paris, France., Siret A; INSERM U1170, Gustave Roussy Institute, Université Paris Saclay, Villejuif, France., Ignacimouttou C; INSERM U1170, Gustave Roussy Institute, Université Paris Saclay, Villejuif, France., Panchal K; Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Australia., Diop M; Gustave Roussy Institute Cancer Campus, Department of Pediatric and Adolescent Oncology, INSERM U1015, Equipe Labellisée Ligue Nationale Contre le Cancer, Université Paris-Saclay, Villejuif, France., Jenni S; Department of Pediatric Oncology, Children's Research Centre, University Children's Hospital Zurich, Zurich, Switzerland., Tsai YC; Department of Pediatric Oncology, Children's Research Centre, University Children's Hospital Zurich, Zurich, Switzerland., Roos-Weil D; INSERM U1170, Gustave Roussy Institute, Université Paris Saclay, Villejuif, France., Aid Z; INSERM U1170, Gustave Roussy Institute, Université Paris Saclay, Villejuif, France., Prade N; Centre of Research on Cancer of Toulouse (CRCT), CHU Toulouse, Université Toulouse III, Toulouse, France., Lagarde S; Centre of Research on Cancer of Toulouse (CRCT), CHU Toulouse, Université Toulouse III, Toulouse, France., Plassard D; IGBMC, Plateforme GenomEast, UMR7104 CNRS, Ilkirch, France., Pierron G; Service de Génétique, Institut Curie, Paris, France., Daudigeos E; Gustave Roussy Institute Cancer Campus, Department of Pediatric and Adolescent Oncology, INSERM U1015, Equipe Labellisée Ligue Nationale Contre le Cancer, Université Paris-Saclay, Villejuif, France., Lecluse Y; Gustave Roussy Institute Cancer Campus, Department of Pediatric and Adolescent Oncology, INSERM U1015, Equipe Labellisée Ligue Nationale Contre le Cancer, Université Paris-Saclay, Villejuif, France., Droin N; INSERM U1170, Gustave Roussy Institute, Université Paris Saclay, Villejuif, France., Bornhauser BC; Department of Pediatric Oncology, Children's Research Centre, University Children's Hospital Zurich, Zurich, Switzerland., Cheung LC; Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Australia.; School of Pharmacy and Biomedical Sciences, Curtin University, Bentley, Australia., Crispino JD; Division of Hematology/Oncology, Northwestern University, Chicago, Illinois., Gaudry M; INSERM U1170, Gustave Roussy Institute, Université Paris Saclay, Villejuif, France., Bernard OA; INSERM U1170, Gustave Roussy Institute, Université Paris Saclay, Villejuif, France., Macintyre E; Hematology, Université de Paris, Institut Necker-Enfants Malades and Assistance Publique-Hopitaux de Paris, Paris, France., Barin Bonnigal C; Centre Hospitalier Universitaire de Tours, Tours, France., Kotecha RS; Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Australia.; School of Pharmacy and Biomedical Sciences, Curtin University, Bentley, Australia.; Department of Clinical Haematology, Oncology and Bone Marrow Transplantation, Perth Children's Hospital, Perth, Australia., Geoerger B; Gustave Roussy Institute Cancer Campus, Department of Pediatric and Adolescent Oncology, INSERM U1015, Equipe Labellisée Ligue Nationale Contre le Cancer, Université Paris-Saclay, Villejuif, France., Ballerini P; Laboratoire d'Hématologie, Hôpital Trousseau, APHP, Paris-Sorbonne, Paris, France., Bourquin JP; Department of Pediatric Oncology, Children's Research Centre, University Children's Hospital Zurich, Zurich, Switzerland., Delabesse E; Centre of Research on Cancer of Toulouse (CRCT), CHU Toulouse, Université Toulouse III, Toulouse, France., Mercher T; INSERM U1170, Gustave Roussy Institute, Université Paris Saclay, Villejuif, France.; Equipe Labellisée Ligue Nationale Contre le Cancer, Paris, France., Malinge S; INSERM U1170, Gustave Roussy Institute, Université Paris Saclay, Villejuif, France. sebastien.malinge@telethonkids.org.au.; Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Australia.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Jul 01; Vol. 26 (13), pp. 3307-3318. Date of Electronic Publication: 2020 Mar 27.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-3265
DOI:10.1158/1078-0432.CCR-19-3519